ARTA
ALBO

A.R.T. Advisors’s Albireo Pharma Inc ALBO Stock Holding History

A.R.T. Advisors’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-610
Closed -$18K – 1671
2015
Q2 		$18K Sell
610
-196
-24% -$6.58K ﹤0.01% 1435
2015
Q1 		$28K Buy
+806
New +$34K ﹤0.01% 1375
2013
Q4 		– Sell
-493
Closed -$46K – 1582
2013
Q3 		$46K Buy
+493
New +$64.2K ﹤0.01% 1258

Other funds holding ALBO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

A.R.T. Advisors's ALBO Position: Q3 2015 in Review

A.R.T. Advisors sold out of Albireo Pharma Inc (ALBO) in Q3 2015, closing a stake of 610 shares — an estimated $18K sold.

A.R.T. Advisors first reported a position in ALBO in Q3 2013 and held it in 3 quarters. The position peaked at $46K in Q3 2013. 38 funds tracked by Wall St. Rank hold ALBO as of Q3 2015.

  • A.R.T. Advisors reported no remaining Albireo Pharma Inc position as of Q3 2015 after selling out during the quarter.
  • A.R.T. Advisors sold 610 Albireo Pharma Inc shares in Q3 2015, an estimated $18K.
  • A.R.T. Advisors first reported a position in Albireo Pharma Inc in Q3 2013 and held it in 3 quarters.
  • A.R.T. Advisors's Albireo Pharma Inc position peaked at $46K in Q3 2013.
  • 38 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q3 2015.

Based on A.R.T. Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.